Trial
NCT06705140
A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi Pasteur, a Sanofi Company
Collaborators
—
Condition
RSV Immunisation
Intervention
Low Dose (LD) RSVt vaccine
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03